Skip to content

CP Research Press Release

Spelman Clinical Research Workshop: Hosted by  Covenant Pulmonary Research. 

November 6, 2023

Historically, Black women have been underrepresented in clinical trials. For example, only 3 percent of participants in clinical trials that led to Food and Drug Administration (FDA) approval of cancer drugs between 2008 and 2018 were Black. Additionally, when we look at the history of clinical trials, specifically the standard of care for Black women in trials, there can be minimal consideration on how specific drugs work with our bodies and genotypes.

Through this community engagement series at higher education institutions, Dr Orjioke hopes to encourage women of color to consider a career in clinical research, through volunteer opportunities and internships.

We hoped to educate and empower by educating students on the following:

  • The things that happened 50 years ago can’t happen now — there are laws in place to protect you when you participate in clinical trials.
  • This is a viable and potentially life saving option for many Black women, a career in clinical research is advocacy.
  • When you participate in a clinical trial, you have better outcomes because you get more supervision from doctors, more scans, more treatment, and more blood work.
  • Because we don’t have enough data on the current drugs for Black women, any time a Black woman gets treatment, she could be doing a clinical trial on her own body.

Clinical trials can save the lives of people in our communities. We would like to thank Spelman College for kicking off our research series!

Ngozika Orjioke, Founder of CP Research, co-hosted the panel discussion at the 2023 Sonar Clinical Research Diversity in Clinical Trials Summit.

The Diversity in Clinical Trials Summit, held on April 22nd, 2023, at The Gathering Spot, Atlanta Ga proved to be an extraordinary community event focused on promoting  diversity  and inclusion within the field of clinical research.

The summit brought together renowned experts,thought leaders,healthcare professionals, patient advocates, and industry representatives.

It resulted in significant progress towards equitable representation in clinical trials. The Diversity in Clinical Trials Summit concluded with a call to action. It urged all stakeholders in the healthcare ecosystem to embrace diversity as an imperative in clinical trials.